Lindsay B. Alcaraz

Characterization of a selective and potent antagonist of human P2X₇receptors, AZ11645373

Leanne Stokes, Lindsay B. Alcaraz, Julian Bent et al. · British Journal of Pharmacology · 2006 · 131 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 128 citations

Medicine, Oncology, Breast Oncology +9

Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β

Lindsay B. Alcaraz, Jean‐Yves Exposito, Nicolas Chuvin et al. · The Journal of Cell Biology · 2014 · 94 citations

Life Sciences, Cell Biology, Molecular Biology +14

Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies

Yahya Ashraf, Hanane Mansouri, Valérie Laurent‐Matha et al. · Journal for ImmunoTherapy of Cancer · 2019 · 92 citations · Full text

Medicine, Cancer Biology, Oncology +17

Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS G12D -driven Pancreatic Tumorigenesis

Nicolas Chuvin, David F. Vincent, Roxane M. Pommier et al. · Cellular and Molecular Gastroenterology and Hepatology · 2017 · 70 citations · Full text

Medicine, Cell Biology, Oncology +17